Conclusions
The role of cyclic AMP in the control of somatostatin release may be primarily that of a modulator without being an essential factor for initiation of somatostatin release. Much work is, however, still required to elucidate the exact nature of the role of cyclic AMP in the secretory mechanism of the D cell. All of the present evidence, however, points to a key regulatory role for calcium in the cascade of events that proceeds to the somatostatin secretion [24, 26, 30–33]. The data indicate that the changes in somatostatin secretion provoked by alterations in the extra-and intracellular levels of Na+ and K+ are secondary to changes in the intracellular level of calcium in the D cell. Caution should, however, be exercised in deducing from the results from cation fluxes in whole islets because of the mixed cell population studied. They cannot be assumed to represent the responses of the D cell alone because these cells make up only 5–15% of the total cell mass in the islet.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arimura A, Coy DH, Chihara M, Fernandez-Durango R, Samols E, Chihara K, Meyers CA, Schally AV (1978) Somatostatin. In: Bloom SR (ed) Gut hormones. Churchill Livingstone, Edinburgh London New York, p 437–445
Ashcroft SJA, Chatra L, Weerasinghe C, Randle PJ (1973) Interrelationship of islet metabolism, adenosine triphosphate content and insulin release. Biochem J 132: 223–231
Barden N, Alvarado-Urbina G, Cote J-P, Dupont A (1976) Cyclic AMP-dependent stimulation of somatostatin secretion by isolated rat islets of Langerhans. Biochem Biophys Res Commun 71: 840–844
Barden N, Cote J-P, Lavoie M, Dupont A (1978) Secretion of somatostatin by rat islets of Langerhans and gastric mucosa and a role for pancreatic somatostatin in the regulation of glucagon release. Metabolism 27 [Suppl 1]: 1215–1218
Berelowitz M, Kronheim S, Pimstone B, Shapiro B (1978) Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose. J Clin Invest 61: 1410–1414
Blaustein MP (1974) The interrelationship between sodium and calcium fluxes across cell membranes. Rev Physiol Biochem Pharmacol 70: 33–82
Brown M, Rivier J, Vale W (1979) Somatostatin: Central nervous system actions on glucoregulation. Endocrinology 104: 1709–1715
Conlon JM, Srikant CB, Ipp E, Schusdziarra V, Vale W, Unger RH (1978) Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma. J Clin Invest 62: 1187–1193
Curry DL, Bennett LL, Grodsky GM (1968) Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 83: 572–584
Dean PM, Matthews EK (1970) Electrical activity in pancreatic islet cells. Effect of ions. J Physiol (Lond) 210: 265–275
Dolais-Kitabgi J, Freychet P (1979) Neurotensin inhibits glucose but not glucagon-induced insulin and somatostatin release in isolated islets. Diabete Metab 5: 275–277
Dolais-Kitabgi J, Kitabgi P, Brazeau P, Freychet P (1979) Effect of neurotensin on insulin, glucagon, and somatostatin release from isolated pancreatic islets. Endocrinology 105: 256–260
Douglas WW (1968) Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. Br J Pharmacol 34: 451–474
Dubois MP (1975) Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci USA 72: 1340–1343
Efendić S, Enzmann F, Nylén A, Uvnäs-Wallensten K, Luft R (1979) Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas. Proc Natl Acad Sci USA 76: 5901–5904
Efendić S, Enzmann F, Nylén A, Uvnäs-Wallensten K, Luft R (1980) Sulphonylurea (glibenclamide) enhances somatostatin and inhibits glucagon release induced by arginine. Acta Physiol Scand 108: 231–233
Efendić S, Nylén A, Roovete A, Uvnäs-Wallensten K (1978) Effects of glucose and arginine on the release of immunoreactive somatostatin from the isolated perfused rat pancreas. FEBS Lett 92: 33–35
Fujita T, Yanatori Y, Murakami T (1976) Insulo-acinar axis, its vascular basis and its functional and morphological changes caused by CCK-PZ and caerulein. In: Fujita T (ed) Endocrine gut and pancreas. Elsevier, Amsterdam, p 347–357
Gerich J, Greene K, Hara M, Rizza R, Patton G (1979) Radioimmunoassay of somatostatin and its application in the study of pancreatic somatostatin secretion in vitro. J Lab Clin Med 93: 1009–1017
Goto Y, Seino Y, Taminato T, Kadowaki S, Chiba T, Note S, Imura H (1979) Theophylline: Potentiation of arginineinduced somatostatin release from the isolated rat pancreas. Diabetes 28: 457–459
Grodsky GM, Batts AA, Bennett LL, Vcella C, McWilliams NB, Smith DF (1963) Effects of carbohydrates on secretion of insulin from isolated rat pancreas. Am J Physiol 205: 638–644
Hansen AaP, Lundbæk K (1976) Somatostatin: A review of its effects especially in human beings. Diabete Metab 2: 203–218
Hara M, Patton G, Gerich J (1979) Increased somatostatin release from pancreases of alloxan diabetic rats perfused in vitro. Life Sci 24: 625–628
Hermansen K (1979) Characterization of somatostatin release from the isolated, perfused canine pancreas: The role of cations. Excerpta Medica 481: 90–91
Hermansen K (1980) Duodenal contribution to pancreaticoduodenal vein islet hormones during stimulation of the canine pancreas with calcium. Diabetes 29: 361–364
Hermansen K (1980) The role of sodium in somatostatin secretion: Evidence for the involvement of Na+ channels in the release mechanisms. Endocrinology 106: 1843–1847
Hermansen K (1980) Effects of substance P and other peptides on the release of somatostatin, insulin and glucagon in vitro. Endocrinology 107: 256–261
Hermansen K (1980) Characterization of the abnormal D-cell function in streptozotocin diabetes (Abstr). Diabetologia 19: 283
Hermansen K (in press) Pancreatic D cell recognition of D-glucose. Studies with D-glucose, D-glyceraldehyde, dihydroxyacetone, D-mannoheptulose, D-fructose, D-galactose, and D-ribose. Diabetes
Hermansen K, Christensen SE, Ørskov H (1979) Characterisation of somatostatin release from the pancreas. The role of calcium and acetylcholine. Diabetologia 16: 261–266
Hermansen K, Christensen SE, Ørskov H (1979) Characterisation of somatostatin release from the pancreas: The role of potassium. Scand J Clin Lab Invest 39: 717–722
Hermansen K, Christensen SE, Ørskov H (1980) The significance of Na+/K+ pump for somatostatin release. Horm Metab Res 12: 23–25
Hermansen K, Christensen SE, Ørskov H, Lundbæk K (1978) Release of somatostatin in response to calcium, glucose, arginine, acetylcholine, and isoproterenol. Acta Endocrinol (Kbh) 88 [Suppl 219]: A 36
Hermansen K, Ørskov H, Christensen SE (1979) Streptozotocin diabetes: A glucoreceptor dysfunction affecting D cells as well as B and A cells. Diabetologia 17: 385–389
Hermansen K, Schwartz TW (1979) Differential sensitivity to somatostatin of pancreatic polypeptide, glucagon, and insulin secretion from the isolated perfused canine pancreas. Metabolism 28: 1229–1233
Honey RN, Schwart JA, Mathe CJ, Weir GC (1980) Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum. Am J Physiol 238: E150-E156
Honey RN, Weir GC (1979) Insulin stimulates somatostatin and inhibits glucagon secretion from the perfused chicken pancreas-duodenum. Life Sci 24: 1747–1750
Ipp E, Dobbs RE, Arimura A, Vale W, Harris V, Unger RH (1977) Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest 60: 760–765
Ipp E, Dobbs RE, McCorkle K, Harris V, Unger RH (1978) Further evidence for similar secretory responses of pancreatic somatostatin and insulin. Clin Res 26: 33A
Ipp E, Dobbs RE, Harris V, Arimura A, Vale W, Unger RH (1977) The effects of gastrin, gastric inhibitory polypeptide, secretin and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. I Clin Invest 60: 1216–1219
Ipp E, Dobbs RE, Unger RH (1978) Vasoactive intestinal peptide stimulates pancreatic somatostatin release. FEBS Lett 90: 76–78
Ipp E, Dobbs R, Unger RH (1978) Morphine and betaendorphin influence the secretion of the endocrine pancreas. Nature 276: 190–191
Ipp E, Rivier J, Dobbs RE, Brown M, Vale W, Unger RH (1979) Somatostatin analogs inhibit somatostatin release. Endocrinology 104: 1270–1273
Ishida T, Röjdmark S, Bloom G, Chou MCY, Field JB (1980) The effect of somatostatin on the hepatic extraction of insulin and glucagon in anesthetized dogs. Endocrinolgy 106: 220–230
Iversen J, Miles DW (1971) Evidence for a feed-back inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes 20: 1–10
Kadowaki S, Taminato T, Chiba T, Mori K, Abe H, Goto Y, Seino Y, Matsukura S, Nozawa M, Fujita T (1979) Somatostatin release from isolated perfused rat pancreas. Possible role of endogenous somatostatin on insulin release. Diabetes 28: 600–603
Kazumi T, Utsumi M, Yoshino G, Ishihara K, Hirose Y, Makimura H, Baba S (1980) Somatostatin concentration responds to arginine in portal plasma. Effects of fasting, streptozotocin diabetes, and insulin administration in diabetic rats. Diabetes 29: 71–73
Kohen E, Kohen C, Thorell B, Mintz DH, Rabinovitch A (1979) Intercellular communication in pancreatic islet monolayer cultures: A microfluorometric study. Science 204: 862–865
Landgraf R, Kotler-Brajtburg J, Matschinsky FM (1971) Kinetics of insulin release from the perfused rat pancreas caused by glucose, glucosamine, and galactose. Proc Natl Acad Sci USA 68: 536–540
Larsson L-I (1979) Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoreactive nerves. J Histochem Cytochem 27: 1283–1284
Larsson L-I, Goltermann N, de Magistris L, Rehfeld JF, Schwartz TW (1979) Somatostatin cell processes as pathways for paracrine secretion. Science 205: 1393–1395
Larsson L-I, Rehfeld JF (1979) Peptidergic and adrenergic innervation of pancreatic ganglia. Scand J Gastroenterol 14: 433–437
Luft R, Efendić S, Hökfelt T (1978) Somatostatin — Both hormone and neurotransmitter? Diabetologia 14: 1–13
McIntosh C, Schauder P, Arnold R, Frerichs H, Creutzfeldt W (1978) Somatostatin release from isolated rat pancreatic islets: Reversal of D-glyceraldehyde induced inhibition and the dynamics of release in a perifusion system. In: Bloom SR (ed) Gut hormones. Churchill Livingstone, Edinburgh London New York, p 453–456
McQuillan MT (1977) Somatostatin, vol I: Annual research reviews. Churchill Livingstone, Edinburgh, p 87–88
Malaisse-Lagae F, Malaisse WJ (1971) Stimulus-secretion coupling of glucose-induced insulin release. III. Uptake of 45calcium by isolated islets of Langerhans. Endocrinology 88: 72–80
Noe BD, Spiess J, Rivier JE, Vale W (1979) Isolation and characterization of somatostatin from Anglerfish pancreatic islet. Endocrinology 105: 1410–1415
Orci L, Baetens D, Dubois MP, Rufener C (1975) Evidence for the D-cell of the pancreas secreting somatostatin. Horm Metab Res 7: 400–402
Orci L, Baetens D, Rufener C, Amherdt M, Ravazzola M, Studer P, Malaisse-Lagae F, Unger RH (1976) Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci USA 73: 1338–1342
Orci L, Malaisse-Lagae F, Ravazzola M, Rouiller D, Renold AE, Perrelet A, Unger RH (1975) A morphological basis for the intercellular communication between α-and β-cells in the endocrine pancreas. J Clin Invest 56: 1066–1070
Orci L, Unger RH (1975) Functional subdivision of islets of Langerhans and possible role of D-cells. Lancet II: 1243–1244
Orci L, Unger RH, Renold AE (1973) Structural coupling between pancreatic islet cells. Experientia 29: 1015–1018
Patel YC, Amherdt M, Orci L (1979) Somatostatin secretion from monolayer cultures of neonatal rat pancreas. Endocrinology 104: 676–679
Patel YC, Weir GC (1976) Increased somatostatin content of islets from streptozotocin-diabetic rats. Clin Endocrinol (Oxf) 5: 191–194
Patton GS, Dobbs RE, Orci L, Vale W, Unger RH (1976) Stimulation of pancreatic immunoreactive somatostatin (IRS) release by glucagon. Metabolism 25 [Suppl 1]: 1499
Patton GS, Ipp E, Dobbs RE, Orci L, Vale W, Unger RH (1976) Response of pancreatic immunoreactive somatostatin to arginine. Life Sci 19: 1957–1960
Patton GS, Ipp E, Dobbs RE, Orci L, Vale W, Unger RH (1977) Pancreatic immunoreactive somatostatin release. Proc Natl Acad Sci USA 74: 2140–2143
Pearse AGE, Polak JM (1978) The diffuse neuroendocrine system and the APUD concept. In: Bloom SR (ed) Gut hormones. Churchill Livingstone, Edinburgh London New York, p 33–39
Porte D, Pupo AA (1969) Insulin response to glucose: Evidence for a two pool system in man. J Clin Invest 48: 2309–2319
Randle PJ, Ashcroft SJH, Gill JR (1968) Carbohydrate metabolism and release of hormones. In: Dickens F, Randle PJ, Whelan WJ (eds) Carbohydrate metabolism and its disorders, vol 1. Academic Press, London New York, p 427–447
Redding TW, Coy DH (1974) The disappearance, distribution and excretion of 125I-tyrosine1-growth hormone release inhibiting hormone in mice, rats and man. 56th Meeting of the American Endocrine Society, Atlanta, Georgia, A198
Rehfeld JF (1978) Gastrointestinal hormones and somatostatin release. Gastroenterology 75: 540–541
Rehfeld JF, Larsson L-I, Goltermann NR, Schwartz TW, Hoist JJ, Jensen SL, Morley JS (1980) Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature 284: 33–38
Rouiller D, Schusdziarra V, Harris V, Unger RH (1978) Physiological role of CCK, secretin and GIP in pancreatic and gastric somatostatin release. Clin Res 26: 721A
Samols E, Tyler JM, Marks V (1972) Glucagon — Insulin interrelationships. In: Lefebvre P, Unger RH (eds) Glucagon. Pergamon, New York, p 151–173
Samols E, Weir GC (1979) Adrenergic modulation of pancreatic A, B, and D cells. J Clin Invest 63: 230–238
Samols E, Weir GC, Ramseur R, Day JA, Patel YC (1978) Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyperand hypoglycemic sulfonamides. Metabolism 27 [Suppl 1]: 1219–1221
Schauder P, McIntosh C, Arends J, Arnold R, Frerichs H, Creutzfeldt W (1977) Somatostatin and insulin release from rat pancreatic islets in response to D-glucose, L-leucine, α-ketoisocaproic acid or D-glyceraldehyde: evidence for a regulatory role of adenosine — 3′,5′-cyclic monophosphate. Biochem Biophys Res Commun 75: 630–635
Schauder P, McIntosh C, Arends G, Arnold R, Frerichs H, Creutzfeldt W (1976) Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. FEBS Lett 68: 225–227
Schauder P, McIntosh C, Arends J, Frerichs H (1979) Effect of fasting on the release of insulin and somatostatin from perfused islets of Langerhans. Diabetes 28: 204–207
Schauder P, McIntosh C, Panten U, Arends J, Arnold R, Frerichs H, Creutzfeldt W (1977) Dynamics of somatostatin release from isolated rat pancreatic islets. FEBS Lett 81: 355–358
Schauder P, McIntosh C, Panten U, Arends J, Arnold R, Frerichs H, Creutzfeldt W (1978) Dynamics of somatostatin and insulin release from isolated rat pancreatic islets. Evidence for intra-islet interactions between B cells and D cells. Metabolism 27 [Suppl 1]: 1211–1214
Schauder P, McIntosh C, Schindler B, Panten U, Frerichs H (1978) Comparison of α-ketoisocaproic acid and glucose in rats: effects on insulin and somatostatin release and on islet cAMP content. Mol Cell Endocrinol 11:51–61
Schusdziarra V, Dobbs RE, Harris V, Unger RH (1977) Immunoreactive somatostatin levels in plasma of normal and alloxan diabetic dogs. FEBS Lett 81: 69–72
Schusdziarra V, Harris V, Arimura A, Unger RH (1979) Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients. Endocrinology 104: 1705–1708
Schusdziarra V, Harris V, Conlon JM, Arimura A, Unger RH (1978) Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest 62: 509–518
Schusdziarra V, Harris V, Unger RH (1979) Half-life of somatostatin-like immunoreactivity in canine plasma. Endocrinology 104: 109–110
Schusdziarra V, Ipp E, Harris V, Dobbs RE, Raskin P, Orci L, Unger RH (1978) Studies on the physiology and pathophysiology of the pancreatic D cell. Metabolism 27 [Suppl 1]: 1227–1232
Schusdziarra V, Rouiller D, Arimura A, Unger RH (1978) Antisomatostatin serum increases levels of hormones from the pituitary and gut, but not from the pancreas. Endocrinology 103: 1956–1959
Schusdziarra V, Rouiller D, Harris V, Conlon JM, Unger RH (1978) The response of plasma somatostatin-like immunoreactivity to nutrients in normal and alloxan diabetic dogs. Endocrinology 103: 2264–2273
Schusdziarra V, Rouiller D, Harris V, Unger RH (1979) Gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of a meal. Effects of truncal vagotomy and atropine in the anesthetized dog. Diabetes 28: 658–663
Schusdziarra V, Zysnar E, Rouiller D, Boden G, Brown JC, Arimura A, Unger RH (1980) Splanchnic somatostatin: A hormonal regulator of nutrient homeostasis. Science 207: 530–532
Sehlin J, Täljedal I-B (1974) Transport of rubidium and sodium in pancreatic islets. J Physiol (Lond) 242: 505–515
Sehlin J, Täljedal I-B (1974) Sodium uptake by microdissected pancreatic islets: effects of ouabain and chloromercuribenzene-p-sulphonic acid. FEBS Lett 39: 209–213
Seino S, Sakurai H, Seino Y, Tsuda K, Tanigawa K, Kuzuya H, Goto Y, Imura H (1980) Starvation-induced changes of somatostatin, glucagon, and insulin secretion from the isolated perfused rat pancreas. Diabetes 29: 323–325
Shapiro B, Berelowitz M, Pimstone BL, Kronheim S, Sheppard M (1979) Tissue and serum somatostatin-like immunoreactivity in fed, 15-h-fasted, and 72-h-fasted rats. Diabetes 28: 182–184
Sheppard M, Shapiro B, Pimstone BL, Kronheim S, Berelowitz M, Gregory M (1979) Metabolic clearance and plasma disappearance time of exogenous somatostatin in man. J Clin Endocrinol Metab 48: 50–53
Spiess J, Rivier JE, Rodkey JA, Bennett CD, Vale W (1979) Isolation and characterization of somatostatin from pigeon pancreas. Proc Natl Acad Sci USA 76: 2974–2978
Stagner JI, Samols E, Weir GC (1980) Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration. J Clin Invest 65: 939–942
Stewart JK, Steiner RA, Barber J, Koerker DJ, Goodner CJ, Game GC (1977) Effects of active immunisation against somatostatin on secretion of growth hormone and insulin in adolescent male baboons. Program of 59th Annual Meeting of the Endocrine Society, 348A
Taniguchi H, Utsumi M, Hasegawa M, Kobayashi T, Watanabe Y, Murakami K, Seki M, Tsutou A, Makimura H, Sakoda M, Baba S (1977) Physiologic role of somatostatin. Insulin release from rat islets treated by somatostatin antiserum. Diabetes 26: 700–702
Tannenbaum GS, Epelbaum J, Colle E, Brazeau P, Martin JB (1978) Dissociation of effects of somatostatin antiserum on growth hormone and insulin secretion. Metabolism 27 [Suppl 1]: 1263–1267
Unger RH, Ipp E, Schusdziarra V, Orci L (1977) Hypothesis: physiologic role of pancreatic somatostatin and the contribution of D-cell disorders to diabetes mellitus. Life Sci 20: 2081–2086
Wasada T, Pietri A, Raskin P, Dobbs R, Unger RH (1980) Effect of free fatty acids (FFA) on the gastric and pancreatic secretion of somatostatin-like immunoreactivity. Diabetes 29 [Suppl 2]: 9A
Weir GC, Samols E, Day JA, Patel YC (1978) Glucose and glucagon stimulate the secretion of somatostatin from the perfused canine pancreas. Metabolism 27 [Suppl 1]: 1223–1226
Weir GC, Samols E, Loo S, Patel YC, Gabbey KH (1979) Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine. Diabetes 28: 35–40
Zern RT, Foster LB, Blalock JA, Feldman JM (1979) Characteristics of the dopaminergic and noradrenergic systems of the pancreatic islets. Diabetes 28: 185–189
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hermansen, K. Secretion of somatostatin from the normal and diabetic pancreas. Diabetologia 19, 492–504 (1980). https://doi.org/10.1007/BF00253175
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00253175